baber/WOPTO huggingface dataset:
Patent JP-H067954-B2 (JP)
IPC: C09D133/04
Filed: 1990-12-11
Abstract: PCT No. PCT/EP90/02148 Sec. 371 Date Jul. 28, 1992 Sec. 102(e) Date Jul. 28, 1992 PCT Filed Dec. 11, 1990 PCT Pub. No. WO91/09685 PCT Pub. Date Jul. 11, 1991.A process utilizing a pigmented aqueous basecoat composition which contains as the film-forming material a water-thinnable emulsion polymer. The water-thinnable emulsion polymer is prepared in a two-stage emulsion polymerization. In the first stage a polymer is prepared having a glass transition temperature (TG1) of +30 DEG  to +110 DEG  C. In the second stage a mixture of monomers is polymerized in the presence of the polymer prepared in the first stage, which mixture, polymerized on its own, would give a polymer with a glass transition temperature (TG2) of -60 DEG  to +20 DEG  C. The hydroxyl value of the emulsion polymer is between 2 and 100.
Patent JP-2868313-B2 (JP)
IPC: C07D491/10
Filed: 1991-03-20
Granted: 1999-03-10
Abstract: Heterocyclic N-substituted derivatives of formula (I) and their salts are new. R1, R2 = H, 1-6C alkyl, 1-4C alkoxy, NH2, NH2CH2-, COOH, (1-4C alkoxy)carbonyl, CN, tetrazolyl, methyltetrazolyl, methylsulphonylamino, trifluoromethyl sulphonylamino(methyl), N-cyanoacetamide, N-hydroxy- acetamide, N-((4-carboxy)-1, 3-thiazol-2-yl) acetamido, ureido, 2-cyanoguanidinocarbonyl, 2-cyano-guanidino-methyl, imidazol-1-yl-carbonyl, 3-cyano-2-methyl isothioureidomethyl, with the proviso that R1 and R2 are not both H. R3 = H, 1-6C alkyl (optionally substituted by one or more halogen, 2-6C alkenyl, 3-7C cycloalkyl, Ph, phenyl-(1-3C alkyl) or (2-3C alkenyl)phenyl; the Ph groups are optionally substituted by at least 1 halogen, 1-4C alkyl, halogen-(1-4C alkyl), polyhalogeno-(1-4C alkyl), OH or 1-4C alkoxy. R4, R5 = 1-6C alkyl, Ph, phenyl-(1-3C alkyl), the alkyl, phenyl and phenylalkyl groups being optionally substituted by one or more halogen, perfluoro-(1-4C alkyl), OH or 1-4C alkoxy. Or R4 and R5 together form =CR7R8, (CH2)n or (CH2)pY(CH2)q. R7 = H, 1-4C alkyl or Ph; R8 = 1-4C alkyl or Ph. Y = O, S, C (substituted by 1-4C alkyl, Ph or phenyl-(1-3C alkyl) or NR6. R6 = H, 1-4C alkyl, phenyl-(1-3C alkyl), 1-4C alkylcarbonyl, halogeno-(1-4C(alkyl)carbonyl, polyhalo-(1-4C alkyl)carbonyl, -COPh, alpha-aminoacyl or an N-protecting group. Or R4 and R5 together form indane or adamantane. p + q = m; n = 2-11; m = 2-5; X = O or S. z and t = 0 or one is 0 and the other is 1. Specifically claimed is 2-n-butyl-4- spirocyclopentane -1-((2'-(5-tetrazolyl) biphenyl-4-yl)methyl) -2-imidazolin-5-one.
Patent JP-3580371-B2 (JP)
IPC: A61K39/00
Filed: 1992-10-05
Granted: 2004-10-20
Abstract: A method of altering the specific, systemic immune response of an individual to a target antigen by the co-administration of a cytokine an adhesion or accessory molecule and the target antigen. The target antigen may be a tumor cell, a tumor cell antigen, an infectious agent or other foreign antigen, or other antigens to which an enchanted systemic immune response is desirable. Alternatively, the antigen may be a non-foreign antigen when a suppression of a systemic immune response is desired. The resulting systemic immune response is specific for the target antigen.
Patent JP-3441074-B2 (JP)
IPC: H01H1/02
Filed: 1993-09-16
Granted: 2003-08-25
Abstract: PCT No. PCT/EP93/02511 Sec. 371 Date May 18, 1995 Sec. 102(e) Date May 18, 1995 PCT Filed Sep. 16, 1993 PCT Pub. No. WO94/07252 PCT Pub. Date Mar. 31, 1994A material for electric contacts based on silver-tin oxide is obtained by mixing a powder of silver or an alloy mainly containing silver with a powder consisting mainly of tin oxide and 0.01 to 10 wt. % (in relation to the quantity of tin oxide) of an additive consisting of one or more compounds containing silver, oxygen and a metal from sub-groups II to VI of the periodic system and/or antimony, bismuth, germanium, indium and gallium, compacting the mixture and sintering it. The tin oxide may be replaced by zinc oxide.
Patent JP-H0649052-B2 (JP)
IPC: A61G12/00
Filed: 1990-06-01
Abstract: Apparatus and method for sterilizing and encapsulating contaminated waste particularly medical implement waste in which a volume of thermoplastic compound having a melting point temperature-calibrated at a value which corresponds substantially to the temperature at which all biological contamination is rendered sterile substantially on contact, and impregnating a space containing contaminated waste items with the liquid compound and thereafter cooling the mass to its solidified phase while containing it against protrusion of any waste item.
Patent JP-3032004-B2 (JP)
IPC: A61K47/48
Filed: 1990-06-22
Granted: 2000-04-10
Abstract: This invention relates to a method for synthesizing a substantially pure reactive lipid including, for example, N-[4-(p-maleimidophenyl)-butyryl]phosphatidylethanolamine (MPB-PE) and related compositions. The compositions of the present invention are useful as coupling agents and may be incorporated into liposomes and subseuquently coupled to proteins, cofactors and a number of other molecules. A preferred coupling method is also disclosed as are protein conjugates. The present invention also relates to a general method for producing sized protein-liposome conjugates exhibiting enhanced blood circulation times. The present invention also relates to the sized protein-liposome conjugate compositions produced by the method of the present invention. The protein-liposome conjugates of the present invention preferably range in size from about 75 nm to about 200 nm. The liposomes of the invention may have a trans-membrane potential across their membranes, and may be dehydrated. In addition, the composition may contain ionizable bioactive agents such as antineoplastic agents, and may be used in diagnostic assays.
Patent JP-2728148-B2 (JP)
IPC: A61P43/00
Filed: 1990-07-30
Granted: 1998-03-18
Abstract: Pharmaceutically pure physiologically active N<G>-aminoarginine (i.e., the L or D,L form) or pharmaceutically acceptable salt thereof is administered in a nitric oxide synthesis inhibiting amount to a subject in need of such inhibition (e.g. a subject with low blood pressure or needing immunosuppressive effect) or is added to a medium containing isolated organs, intact cells, cell homogenates or tissue homogenates in an amount sufficient to inhibit nitric oxide formation to elucide or control the biosynthesis, metabolism or physiological role of nitric oxide. N<G>-amino-L-arginine is prepared and isolated as a pharmaceutically pure compound by reducing N<G>-nitro-L-arginine, converting L-arginine by-product to L-ornithine with arginase and separating N<G>-amino-L-arginine from the L-ornithine. N<G>-amino-D,L-arginine is prepared in similar fashion starting with N<G>-nitro-D,L-arginine.
Patent JP-3306063-B2 (JP)
IPC: C12Q1/68
Filed: 1991-08-20
Granted: 2002-07-24
Abstract: The invention provides a method of synthesizing oligonucleotides having random tuplets using individual monomers. The steps consist of: (1) sequentially coupling monomers on separate supports to form at least two different tuplets, the coupling is performed in separate reaction vessels; (2) mixing the supports from the reaction vessels; (3) dividing the mixed supports into two or more separate reaction vessels; and (4) repeating steps (1) through (3) one or more times in the reaction vessels of step (3), wherein the last step ends at step (2). Additionally, the oligonucleotides can be cleaved from the supports.
Patent JP-3242912-B2 (JP)
IPC: G06F3/06
Filed: 1990-09-26
Granted: 2001-12-25
Abstract: The multiple step data read apparatus provides a buffer memory (108-0) for each read/write head (110-0) in the rotating media (111-0) data storage system that can store up to the entire track (400) of data that includes the requested data (Sectors 2-6). The data is fragmented such that the data transferred into the read/write head buffer first is transmitted to the control unit first whether or not that data is at the beginning of the data requested by the control unit. The data is further fragmented such that critical portions of the data are available to the control unit to satisfy the host request as soon as the data is read from the device. This fragmenting results in the data becoming available to the control unit in the minimum time possible and the performance of the subsystem being the maximum possible. In addition each data fragment transfer to the control unit (104) is initiated a predetermined time before the end of the fragment of data such that the read/write head (110-0) reaches the end of the fragment the same time that the last sector of the fragment is transmitted to the control unit (104).
Patent JP-2873090-B2 (JP)
IPC: A61K31/42
Filed: 1993-03-05
Granted: 1999-03-24
Abstract: Novel compounds of Formula (I) <CHEM> are described herein. These compounds inhibit the production of Tumor Necrosis Factor and are useful in the treatment of disease states mediated or exacerbated by TNF production. The compounds of the present invention are also useful in the mediation or inhibition of enzymatic or catalytic activity of phosphodiesterase IV and are therefore useful in the treatment of disease states in need of mediation or inhibition thereof.
Patent JP-3807743-B2 (JP)
IPC: C10M161/00
Filed: 1996-03-27
Granted: 2006-08-09
Abstract: A two-cycle oil is disclosed consisting of a polybutene polymer, solvent and mineral oil which passes the JASO engine test for gasoline fueled two-cycle engines.
Patent JP-4110240-B2 (JP)
IPC: A61F13/49
Filed: 1998-05-21
Granted: 2008-07-02
Abstract: A composite nonwoven fabric is provided for use as a one-piece topsheet and barrier fabric for disposable absorbent articles including diapers, catamenial products, and adult incontinence products. The fabric is engineered to have a strikethrough region that is normally surfactant treated for receiving insults and transporting them to an absorbent core material for storage. The strikethrough region is bounded by liquid barrier regions that are suitable for defining containment structures, including diaper leg cuff. The barrier and strikethrough regions can be designed to have excellent low rewet characteristics and to have balanced properties comparable to or better than conventional spunbonded topsheet at comparable or lower basis weights.
Patent ES-2344724-B2 (ES)
Title: Sistema catalitico hibrido que encapsula al menos un ion metalico porinteraccion directa con la matriz.
Inventor: SOTELO PEREZ EDDY
IPC: B01J21/06
Filed: 2010-04-15
Granted: 2011-02-10
Abstract: Sistema catalítico híbrido que encapsula al
menos un ión metálico por interacción directa con la matriz. 
     Sistema catalítico híbrido, químicamente
estable, que  comprende nanopartículas de una matriz
polimérica inorgánica no funcionalizada constituida por sílice,
titania o circonia y que encapsulan al menos un ión metálico por
interacción directa con la matriz. Estos sistemas catalíticos son de
utilidad en la síntesis de compuestos orgánicos, industria química y
farmacéutica, o en procesos químicos respetuosos con el medio
ambiente característicos de la Química Verde.
Patent ES-2402476-B2 (ES)
Title: Placa para impermeabilización y aislamiento integral de suelos, paredes y cubiertas de construcción, y sistema de aplicación en obras.
Inventor: ANTELO PENSADO ERNESTO
IPC: E02D31/02
Filed: 2011-10-21
Granted: 2014-03-05
Abstract: Placa para impermeabilización y aislamiento integral de suelos, paredes y cubiertas de construcción, constituida a partir de una plancha de plástico celular, idealmente poliestireno extrusionado, con orificios transversales por toda su superficie, recubierta por mortero cementoso polimérico hasta rellenar todos sus orificios y crear una capa armada con fibra de vidrio por el lado de sustentación de los materiales de acabado exterior, y una capa con una pluralidad de resaltes troncocónicos por la cara opuesta de anclaje al muro o paramento de aplicación, que cuando se solapa con otras por acoplamiento machihembrado para formar paneles soporte, delimita una cámara aislante interior que posibilita el flujo de agua residual y la circulación de aire. Permite crear sistemas aislantes-drenantes de alta resistencia a la compresión en las edificaciones, ofreciendo una solución global a los problemas de humedad, ya sea por filtraciones, por condensación o por ascensión capilar.
Patent IE-S86746-B2 (IE)
Title: Method of production of an upper barrel for a device to kill mosquitoes and/or flies
Inventor: GONG ZHU
IPC: A01M1/00
Filed: 2015-09-10
Abstract: The invention relates to a design method for the upper barrel suitable for the device to kill mosquitoes and/or flies. The method comprises providing a first external shell, a circuit controlling board, an actuator and a pillar; arranging a first and second electric motor with drive mechanism, a first and second wire rewinding wheel to the actuator; vertically arranging each axis of the motors to each other; driving the middle barrel moving up and down by the rotation of the wheels in the upper barrel; mosquitoes and/or flies are attracted to the device when the middle barrel is drived to the top portion by the rotation of the wheel, and pressed under water to be drown when the middle barrel is drived to the bottom portion by the rotation of the wheel, the killing course do not cause secondary pollution or threat to health. <Figure 17>
Patent AU-2001246954-B2 (AU)
Title: Flavouring a foodstuff with compounds containing a sulfur atom linked to two specific atoms or groups
Inventor: BOUTER NICO
IPC: A23L27/20
Filed: 2001-04-05
Granted: 2006-02-02
Abstract: The invention relates to a process for flavouring foodstuffs by incorporating therein an effective amount of at least one compound R1-S-R2 with a specific, well defined structure such as propyl-2-mercaptopropionate; methyl-2-mercapto-propionate; S-ethyl thioformate; S-ethyl-2-(acetylamino)thioacetate; N-(2-methylthioethyl)acetamide; 2-propenylthiol; 4-methyl-2-3H-thiazolone or tautomer; and 2,3-dimethyl-4-formylthiophene. The invention also covers a foodstuff and/or a flavouring concentrate containing at least one of the above identified compounds.
Patent AU-2001248498-B2 (AU)
Title: Pipette provided with sampled volume adjusting means
Inventor: VIOT FRANCOIS
IPC: G01N1/00
Filed: 2001-04-09
Granted: 2005-06-16
Abstract: The sampling pipette includes means for adjusting the volume of liquid to be taken. It includes a locking element that is movable between an inactive position in which it makes the adjustment means unsuitable for performing adjustment and an active position in which it makes the adjustment means suitable for performing adjustment.
Patent AU-2001284640-B2 (AU)
Title: Acid stable membranes for nanofiltration
Inventor: KURTH CHRISTOPHER J
IPC: B01D71/62
Filed: 2001-05-23
Granted: 2007-01-04
Abstract: Semi-permeable membranes are described that allow for the efficient processing of many liquid based feed solutions, particularly those that contain acids. The membranes of this invention are able to process such feeds with high permeate rates while maintaining excellent retention of dissolved metals, cations, and organic compounds, even in the presence of hot concentrated acids. The semi-permeable membranes of this invention are able to conduct such separations for a useful period of time due to their chemical stability towards acids and their ability to permeate acids.
Patent AU-2002236042-B2 (AU)
Title: Adjustable saddle
Inventor: WALKER DANIEL ALEXANDER LLOYD
IPC: B68C1/00
Filed: 2002-03-01
Granted: 2006-08-03
Abstract: An equestrian saddle comprises a modular construction including a tree having two side panels connected by a bridge of hinged construction whereby the side panels are angularly adjustable, and a seat plate secured to the side panels.
Patent AU-2002300702-B2 (AU)
Title: Extended wear ophthalmic lens
Inventor: SCHINDHELM KLAUS
IPC: C08K3/00
Filed: 2002-08-21
Granted: 2005-12-15
Abstract: An ophthalmic lens is disclosed which is suited for extended-wear periods of at least one day on the eye without a clinically significant amount of corneal swelling and without substantial wearer discomfort. The lens has a balance of oxygen permeability and ion or water permeability, with the ion or water permeability being sufficient to provide good on-eye movement, such that a good tear exchange occurs between the lens and the eye. A preferred lens is a copolymerization product of an oxyperm macromer and an ionoperm monomer. The invention encompasses extended wear contact lenses, which include a core having oxygen transmission and ion transmission pathways extending from the inner surface to the outer surface.
Patent AU-2002320663-B2 (AU)
Title: Supra-renal prosthesis and renal artery bypass
Inventor: LANDAU GEORGE D
IPC: A61F2/82
Filed: 2002-12-20
Granted: 2007-09-06
Abstract: A system for bypassing an aneurysm comprises a first prosthesis and at least one second prosthesis communicating with the first prosthesis, and at least one third prosthesis communicating with the first prosthesis. The first prosthesis comprises a proximal end configured to engage a section of artery upstream of a junction between a first artery and a second artery. The second prosthesis is configured to bypass the aneurysm. The third prosthesis is configured to provide a fluid flow channel from the first artery into the second artery. <IMAGE>
Patent AU-2002329740-B2 (AU)
Title: Multiple zone apertured web
Inventor: JOHNSON PHILIP S
IPC: A61F13/15
Filed: 2002-08-13
Granted: 2008-10-02
Abstract: The invention provides an apertured web comprising multip        le, discrete zones comprising arrangements of land areas and at least two apertures.
Patent AU-2003215022-B2 (AU)
Title: Stethoscope
Inventor: DRUMMOND THOMAS E
IPC: A61B7/02
Filed: 2003-03-21
Granted: 2008-08-14
Abstract: A chestpiece for a stethoscope, the chestpiece having a novel mix of desirable properties through being fabricated from the group of materials known as "high gravity compounds." These compounds are prepared by loading various plastic resins with high density metal powders. In spite of the metallic content, appropriate compounds can be injection molded, providing economic and aesthetic advantages.
Patent AU-2003243846-B2 (AU)
Title: Viral inhibitors
Inventor: NEYTS JOHAN
IPC: C07D471/04
Filed: 2003-07-03
Granted: 2008-11-20
Abstract: This invention relates to a class of imidazo[4,5-c]pyridine compounds which are useful for the treatment or prevention of a viral infection, and for inhibiting the replication of a virus of the family of the Flaviviridae or the Picornaviridae such as BVDV, HCV or Cocxsackie virus.  This invention relates to a process for preparing this class of imidazo[4,5-c]pyridine compounds.
Patent AU-2003249582-B2 (AU)
Title: Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
Inventor: JASTI VENKATESWARLU
IPC: A61K9/02
Filed: 2003-06-19
Granted: 2006-08-03
Abstract: The present invention relates to novel tetracyclic arylsulfonyl indoles, their derivatives, their analogues, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates, novel intermediates described herein and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel tetracyclic arylsulfonyl indoles of the general formula (I), their derivatives, their analogues, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates, novel intermediates described herein and pharmaceutically acceptable compositions containing them. This invention also relates to process/es for preparing such compound/s of general formula (I), composition/s containing effective amount/s of such a compound and the use of such a compound/composition in therapy.
Patent AU-2004203196-B2 (AU)
Title: Method of Delivery of Supplementary Information
Inventor: LAPSTUN PAUL
IPC: G06F3/12
Filed: 2004-07-15
Granted: 2007-08-02
Abstract: A system for capturing an electronic message is disclosed. The system includes a printer, a sensing device and a computer system. The printer prints on a substrate user information visible to a user and coded tags invisible to the user. Each coded tag encodes an identity unique to the substrate and a location of the coded tag on the substrate. The user information defines a message area on the substrate. The sensing device senses the coded tags on the substrate when the sensing device is moved relative to the substrate. The computer system electronically captures a message composed with the sensing device via movement of the sensing device relative to the message area, the computer system using the identity of the substrate and a sequence of respective locations of coded tags sensed by the sensing device for determining the movement relative to the message area and the message.
Patent AU-2004291054-B2 (AU)
Title: Bladder for an article of footwear
Inventor: GOODWIN DAVID
IPC: A43B13/20
Filed: 2004-11-08
Granted: 2010-04-22
Abstract: A fluid-filled bladder (40) for an article of footwear is disclosed that includes a sealed outer barrier (50) and a tensile member (60). The barrier is substantially impermeable to a fluid contained by the bladder, and the tensile member is located within the barrier and bonded to opposite sides of the barrier. The tensile member (60) defines a flexion area (65) that promotes flexing of a first portion (64a) of the bladder with respect to a second portion (63b) of the bladder. The flexion area is an area where the tensile member is absent, and the flexion area may have the configuration of a space, aperture, or indentation, for example.
Patent AU-2004319276-B2 (AU)
Title: Monoclonal antibodies to hepatocyte growth factor
Inventor: SU YI-CHI
IPC: A61K39/395
Filed: 2004-08-13
Granted: 2010-08-26
Abstract: The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
Patent AU-2004323018-B2 (AU)
Title: Pd-containing coating for low chlorine overvoltage
Inventor: DIFRANCO DINO F
IPC: C25B11/04
Filed: 2004-09-01
Granted: 2011-09-15
Abstract: The present invention relates to an electrocatalytic coating and an electrode having the coating thereon, wherein the coating is a mixed metal oxide coating, preferably platinum group metal oxides with or without valve metal oxides, and containing a transition metal component such as palladium, rhodium or cobalt. The electrocatalytic coating can be used especially as an anode component of an electrolysis cell for the electrolysis of a halogen­containing solution wherein the palladium component reduces the operating potential of the anode and eliminates the necessity of a "break-in" period to obtain the lowest anode potential.
Patent AU-2005201245-B2 (AU)
Title: Swimming Goggles
Inventor: HERMAN CHIANG
IPC: A63B33/00
Filed: 2005-03-23
Granted: 2011-07-07
Abstract: Abstract Swimming goggles (1) comprise a frame (2), eyeglasses (4), a pad (3) and compressing devices (5). The eyeglasses (4) are received in the pad (3), and the compressing devices (5) are mounted on opposite outer sides of the frame (2) for compressing the eyeglasses (4) and the pad (3), wherein each compressing device (5) includes a first cover (50) and a second cover (51) which are assembled together and receive a head strip. The frame (2) has an upper frame (20), a lower frame (21), and a nose support (22). Cracks (70) are defined on both sides of the upper frame (20) and the lower frame (21). The upper (20) frame forms a gap in a middle of an inner edge thereof for making the frame (2) flexible to bend inwardly thereby fitting for various users who have different face profiles. cocir Lnr CoY
Patent AU-2005225208-B2 (AU)
Title: Porous implant for spinal disc nucleus replacement
Inventor: REAH CHRISTOPHER
IPC: A61F2/02
Filed: 2005-03-24
Granted: 2009-11-19
Abstract: A spinal implant is provided in which the implant includes a porous component (7) and one or more filling elements (22) provided within the porous component. Tissue in-growth is promoted.